Holen Sie sich die Stockscreener-App
3.21
1.23%
-0.04
Vorhandelsmarkt:
3.31
0.10
+3.12%
Schlusskurs vom Vortag:
$3.25
Offen:
$3.21
24-Stunden-Volumen:
15,673
Relative Volume:
0.38
Marktkapitalisierung:
$48.02M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.3973
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
-8.55%
1M Leistung:
+1.58%
6M Leistung:
-34.09%
1J Leistung:
+169.75%
1-Tages-Spanne:
$3.145
$3.30
1-Wochen-Bereich:
$3.145
$3.54
52-Wochen-Spanne:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Vergleichen Sie CPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.21 | 48.62M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
How to forecast Cumberland Pharmaceuticals Inc. trends using time seriesJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Heatmap analysis for Cumberland Pharmaceuticals Inc. and competitorsWeekly Market Outlook & Daily Price Action Insights - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidance2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Can Cumberland Pharmaceuticals Inc. stock sustain institutional interestJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Cumberland Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Recap & Safe Capital Investment Plans - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levelsMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
Cumberland Pharmaceuticals (Nasdaq: CPIX) to Report Q3 2025 Results, Hosting Investor Call - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock maintain growth storyEarnings Trend Report & Accurate Intraday Trade Tips - Fundação Cultural do Pará
Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performancePortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Regression analysis insights on Cumberland Pharmaceuticals Inc. performanceJuly 2025 Summary & Fast Momentum Entry Tips - newser.com
How moving averages guide Cumberland Pharmaceuticals Inc. tradingJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
What insider trading reveals about Cumberland Pharmaceuticals Inc. stockWeekly Investment Summary & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Published on: 2025-10-27 22:22:34 - newser.com
Cumberland Pharmaceuticals’ Promising Phase II Study on Ifetroban for IPF - TipRanks
Will Cumberland Pharmaceuticals Inc. stock rally after Fed decisionsWeekly Loss Report & Verified Trade Idea Suggestions - Fundação Cultural do Pará
Published on: 2025-10-26 18:19:48 - newser.com
Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.2025 Market WrapUp & Expert Approved Trade Ideas - newser.com
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.51%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):